BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 22555486)

  • 21. Vascular endothelial growth factor, left ventricular dysfunction and mortality in hemodialysis patients.
    Mallamaci F; Benedetto FA; Tripepi G; Cutrupi S; Pizzini P; Stancanelli B; Seminara G; Bonanno G; Rapisarda F; Fatuzzo P; Malatino LS; Zoccali C
    J Hypertens; 2008 Sep; 26(9):1875-82. PubMed ID: 18698224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resistin - concentrations in persons with type 2 diabetes mellitus and in individuals with acute inflammatory disease.
    Stejskal D; Adamovská S; Bartek J; Juráková R; Prosková J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2003 Nov; 147(1):63-9. PubMed ID: 15034607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute effect of standard heparin versus low molecular weight heparin on oxidative stress and inflammation in hemodialysis patients.
    Poyrazoglu OK; Dogukan A; Yalniz M; Seckin D; Gunal AL
    Ren Fail; 2006; 28(8):723-7. PubMed ID: 17162433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum triiodothyronine level as an indicator of inflammation in patients undergoing dialysis.
    Zeraati AA; Layegh P; Famili Y; Naghibi M; Sharifipour F; Shariati Sarabi Z
    Iran J Kidney Dis; 2011 Jan; 5(1):38-44. PubMed ID: 21189433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of hepatitis C virus on C-reactive protein and interleukin-6 in hemodialysis patients.
    Afzal N; Abbas S; Ahmed A; Arif M; Javeed K
    Iran J Kidney Dis; 2011 Jul; 5(3):182-6. PubMed ID: 21525578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammatory cytokines and malnutrition as related to risk for cardiovascular disease in hemodialysis patients.
    Perunicic-Pekovic G; Pljesa S; Rasic-Milutinovic Z; Stankovic S; Ilic M; Maletic R
    Can J Physiol Pharmacol; 2008 Apr; 86(4):205-9. PubMed ID: 18418430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum amyloid A, C-reactive protein and remnant-like lipoprotein particle cholesterol in type 2 diabetic patients with coronary heart disease.
    Hamano M; Saito M; Eto M; Nishimatsu S; Suda H; Matsuda M; Matsuki M; Yamamoto S; Kaku K
    Ann Clin Biochem; 2004 Mar; 41(Pt 2):125-9. PubMed ID: 15025802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Another angiogenic gene linked to amyotrophic lateral sclerosis.
    Lambrechts D; Lafuste P; Carmeliet P; Conway EM
    Trends Mol Med; 2006 Aug; 12(8):345-7. PubMed ID: 16843725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma pentraxin-3 as a marker of bioincompatibility in hemodialysis patients.
    Oldani S; Finazzi S; Bottazzi B; Garlanda C; Baldassarre E; Valaperta S; Cuccovillo I; Albini M; Child M; Montanelli A; Graziani G; Badalamenti S
    J Nephrol; 2012; 25(1):120-6. PubMed ID: 21725917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Airway angiogenesis in stable and exacerbated chronic obstructive pulmonary disease.
    Kristan SS; Marc MM; Kern I; Flezar M; Suskovic S; Kosnik M; Korosec P
    Scand J Immunol; 2012 Jan; 75(1):109-14. PubMed ID: 21916917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in Type 1 diabetic patients without clinically manifest macroangiopathy.
    Targher G; Bertolini L; Zoppini G; Zenari L; Falezza G
    Diabet Med; 2005 Aug; 22(8):999-1004. PubMed ID: 16026364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gamma-tocopherol and docosahexaenoic acid decrease inflammation in dialysis patients.
    Himmelfarb J; Phinney S; Ikizler TA; Kane J; McMonagle E; Miller G
    J Ren Nutr; 2007 Sep; 17(5):296-304. PubMed ID: 17720098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
    Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G
    Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma adiponectin: a predictor of coronary heart disease in hemodialysis patients--a Japanese prospective eight-year study.
    Takemoto F; Katori H; Sawa N; Hoshino J; Suwabe T; Nakanishi S; Arai S; Fukuda S; Kodaka K; Shimada M; Yamazaki C; Yokoyama K; Nakano Y; Funahashi T; Ubara Y; Yamada A; Takaichi K; Uchida S
    Nephron Clin Pract; 2009; 111(1):c12-20. PubMed ID: 19052467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diabetes in hemodialysis: study of differential factors].
    Sanz París A; Lou Arnal LM; Gutiérrez Colón JA; Alvarez Lipe A; Albero Gamboa R
    An Med Interna; 1998 Apr; 15(4):183-8. PubMed ID: 9608060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High serum angiogenin at diagnosis predicts for failure on long-term treatment response and for poor overall survival in non-Hodgkin lymphoma.
    Fang S; Repo H; Joensuu H; Orpana A; Salven P
    Eur J Cancer; 2011 Jul; 47(11):1708-16. PubMed ID: 21439815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients.
    Falciani M; Gori AM; Fedi S; Chiarugi L; Simonetti I; Dabizzi RP; Prisco D; Pepe G; Abbate R; Gensini GF; Neri Serneri GG
    Thromb Haemost; 1998 Mar; 79(3):495-9. PubMed ID: 9531029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In patients with coronary artery disease endothelial function is associated with plasma levels of C-reactive protein and is improved by optimal medical therapy.
    Vitale C; Cerquetani E; Wajngarten M; Leonardo F; Silvestri A; Mercuro G; Fini M; Ramires JA; Rosano GM
    Ital Heart J; 2003 Sep; 4(9):627-32. PubMed ID: 14635381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.
    Lip PL; Belgore F; Blann AD; Hope-Ross MW; Gibson JM; Lip GY
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2115-9. PubMed ID: 10892852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased urinary orosomucoid excretion: a proposed marker for inflammation and endothelial dysfunction in patients with type 2 diabetes.
    Christiansen MS; Iversen K; Larsen CT; Goetze JP; Hommel E; Mølvig J; Pedersen BK; Magid E; Feldt-Rasmussen B
    Scand J Clin Lab Invest; 2009; 69(2):272-81. PubMed ID: 18972260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.